[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PE26691A1 - Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas - Google Patents

Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas

Info

Publication number
PE26691A1
PE26691A1 PE1991185432A PE18543291A PE26691A1 PE 26691 A1 PE26691 A1 PE 26691A1 PE 1991185432 A PE1991185432 A PE 1991185432A PE 18543291 A PE18543291 A PE 18543291A PE 26691 A1 PE26691 A1 PE 26691A1
Authority
PE
Peru
Prior art keywords
asthma
arthritis
useful
treatment
azabencimidazoles
Prior art date
Application number
PE1991185432A
Other languages
English (en)
Inventor
Anthony Marfat
James Frederick Eggler
Michael Jonathan Fray
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE26691A1 publication Critical patent/PE26691A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO DE FORMULA (I): CARACTERIZADO PORQUE CONSISTE TAL COMO EN: (1) CUANTO A ES - NHCO - o - CONH -, COPULAR II o III LOS COMPUESTOS ASI OBTENIDOS SON UTILES EN EL TRATAMIENTO O PREVENCION DEL ASMA, ARTRITIS Y PSORIASIS
PE1991185432A 1990-05-09 1991-05-08 Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas PE26691A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09

Publications (1)

Publication Number Publication Date
PE26691A1 true PE26691A1 (es) 1991-10-21

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1991185432A PE26691A1 (es) 1990-05-09 1991-05-08 Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas

Country Status (28)

Country Link
EP (1) EP0533695B1 (es)
JP (1) JPH0678340B2 (es)
CN (1) CN1057839A (es)
AP (1) AP224A (es)
AT (1) ATE112567T1 (es)
AU (1) AU642265B2 (es)
BG (1) BG97059A (es)
BR (1) BR9106433A (es)
CA (1) CA2080476A1 (es)
DE (1) DE69104481T2 (es)
DK (1) DK0533695T3 (es)
ES (1) ES2061247T3 (es)
FI (1) FI925053A0 (es)
GT (1) GT199100031A (es)
HU (1) HUT62894A (es)
IE (1) IE911553A1 (es)
IL (1) IL98075A0 (es)
MA (1) MA22151A1 (es)
MY (1) MY105512A (es)
NO (1) NO924290D0 (es)
NZ (1) NZ238089A (es)
PE (1) PE26691A1 (es)
PT (1) PT97616A (es)
RO (1) RO109450B1 (es)
TW (1) TW205549B (es)
WO (1) WO1991017163A1 (es)
YU (1) YU81191A (es)
ZA (1) ZA913497B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
WO1994004537A2 (en) * 1992-08-20 1994-03-03 Cytomed, Inc. Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
DE69904318D1 (de) * 1998-05-12 2003-01-16 Wyeth Corp Zur behandlung von insulin-resistenz und hyperglycemie geeignete biphenyl-oxo-essigsäuren
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2015039036A2 (en) 2013-09-13 2015-03-19 Cortendo Ab(Publ) Novel cytochrome p450 inhibitors and their method of use
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
ATE112567T1 (de) 1994-10-15
BR9106433A (pt) 1993-05-04
HU9203496D0 (en) 1993-01-28
AU7867191A (en) 1991-11-27
DK0533695T3 (da) 1995-01-09
WO1991017163A1 (en) 1991-11-14
EP0533695A1 (en) 1993-03-31
DE69104481D1 (de) 1994-11-10
NO924290L (no) 1992-11-06
JPH0678340B2 (ja) 1994-10-05
YU81191A (sh) 1994-06-10
EP0533695B1 (en) 1994-10-05
ES2061247T3 (es) 1994-12-01
BG97059A (bg) 1993-12-24
AP224A (en) 1992-10-27
DE69104481T2 (de) 1995-02-09
FI925053A (fi) 1992-11-06
FI925053A0 (fi) 1992-11-06
IL98075A0 (en) 1992-06-21
MY105512A (en) 1994-10-31
MA22151A1 (fr) 1991-12-31
PT97616A (pt) 1992-03-31
HUT62894A (en) 1993-06-28
CA2080476A1 (en) 1991-11-10
JPH05505619A (ja) 1993-08-19
GT199100031A (es) 1992-10-30
TW205549B (es) 1993-05-11
AU642265B2 (en) 1993-10-14
NZ238089A (en) 1992-10-28
NO924290D0 (no) 1992-11-06
ZA913497B (en) 1992-12-30
IE911553A1 (en) 1991-11-20
CN1057839A (zh) 1992-01-15
AP9100259A0 (en) 1991-07-31
RO109450B1 (ro) 1995-02-28

Similar Documents

Publication Publication Date Title
ES2086505T3 (es) Procedimiento de preparacion de un derivado n-fenilacetico de tetrahidrotieno(3,2-c)piridina y su producto intermedio de sintesis.
ES2060883T3 (es) Procedimiento de obtencion del acido carnosico.
ATE57946T1 (de) Schlagzaehe polyamid-formmassen.
ES2147780T3 (es) Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
ES2089416T3 (es) Procedimiento de produccion de intermedios para uso en la produccion de alcoxiiminoacetamidas.
DE3380409D1 (de) Diazabicyclo(3.3.1)nonanes
CO4950563A1 (es) Nuevos compuestos
PE26691A1 (es) Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas
ES2082057T3 (es) Esteres del acido acrilico pirimidil-substituidos.
MX9100917A (es) Composicion farmaceutica que comprende compuestos de difenilo
ES2107546T3 (es) Procedimiento para la preparacion de desmetilepipodofilotoxina.
DE60016181D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
PT96585A (pt) Processo para prparacao de uma composicao microbiocida para tratamento de telhas de betao
ES545194A0 (es) Un procedimiento para preparar derivados de purina
UY24009A1 (es) Compuestos ariltio útiles como agentes antivirales y antibacteriales
ES521922A0 (es) Procedimiento para la obtencion de esteres de acido metacrillico.
ES2143973T3 (es) Procedimiento para la preparacion de acidos 7-(3-amino- asi como 3-aminometil-1-pirrolidinil)-3-quinoloncarboxilicos asi como -naftiridoncarboxilicos.
ES2108977T3 (es) Derivados del acido hidroximetilfurazanocarboxilico y su utilizacion en el tratamiento de enfermedades cardiovasculares.
ES2152097T3 (es) Empleo de esteres de acidos hidroxicarboxilicos como espesantes.
ES2053471T3 (es) Empleo de dihidropiridinas condensadas carbociclica y heterociclicamente para la preparacion de agentes cardioprotectores, asi como nuevas dihidropiridinas condensadas heterociclica y carbociclicamente, procedimiento para su preparacion y etapas intermedias para su preparacion.
ES2175371T3 (es) Nuevos derivados de histidina, procedimiento de preparacion y su utilizacion como agentes anti-radicales libres.
ES2069901T3 (es) Procedimiento para la obtencion de acido aminometanofosfonico y acidos aminoetil-fosfinicos.
AR006315A1 (es) Derivados de 1,25 dihidroxi-16,22,23-trisdehidro-colecalciferol, compuestos intermediarios para su exclusivo uso en el procedimiento de obtencion de dichoscompuestos, composicion farmaceutica que los contiene, procedimiento de preparación de dichos derivados y empleo de dichos derivados para preparar
ES554827A0 (es) Procedimiento para preparar acidos hexenoicos.
ES2042132T3 (es) Procedimiento para purificar un aducto de oxidos de alquileno.